112 related articles for article (PubMed ID: 18231740)
1. Expression and significance of Oct4 in bladder cancer.
Xu K; Zhu Z; Zeng F
J Huazhong Univ Sci Technolog Med Sci; 2007 Dec; 27(6):675-7. PubMed ID: 18231740
[TBL] [Abstract][Full Text] [Related]
2. [Expression of OCT4 protein in bladder cancer and its clinicopathological implications].
Zhao P; Liu C; Xu K; Zheng S; Li H; Xu Y; Xu A; Li B; Huang P
Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):643-6. PubMed ID: 22588915
[TBL] [Abstract][Full Text] [Related]
3. Expression of OCT4A: the first step to the next stage of urothelial bladder cancer progression.
Jóźwicki W; Brożyna AA; Siekiera J
Int J Mol Sci; 2014 Sep; 15(9):16069-82. PubMed ID: 25216339
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.
Zhou J; Dong D; Cheng R; Wang Y; Jiang S; Zhu Y; Fan L; Mao X; Gui Y; Li Z; Li X; Shi B
Oncotarget; 2016 Nov; 7(45):72767-72776. PubMed ID: 27611951
[TBL] [Abstract][Full Text] [Related]
5. Expression of transcription factor Oct4 in bladder cancer cell line T24 and its effects on the biological characteristics of the cells.
Zhu Z; Wen J; Zheng X; Wang D; Wang Q; Fan C
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):73-6. PubMed ID: 19224167
[TBL] [Abstract][Full Text] [Related]
6. Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas.
Sedaghat S; Gheytanchi E; Asgari M; Roudi R; Keymoosi H; Madjd Z
Appl Immunohistochem Mol Morphol; 2017 Mar; 25(3):196-202. PubMed ID: 26945449
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.
Abdou AG; El-Wahed MM; Kandil MA; Samaka RM; Elkady N
APMIS; 2013 Oct; 121(10):982-96. PubMed ID: 23594289
[TBL] [Abstract][Full Text] [Related]
8. Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer.
Lu CS; Hsieh JL; Lin CY; Tsai HW; Su BH; Shieh GS; Su YC; Lee CH; Chang MY; Wu CL; Shiau AL
Gene Ther; 2015 Apr; 22(4):305-15. PubMed ID: 25588741
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
Wezel F; Pearson J; Kirkwood LA; Southgate J
Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
[TBL] [Abstract][Full Text] [Related]
10. Expression of the cancer stem cell marker OCT4 is associated with worse prognosis and survival in cutaneous melanoma.
Silva CTX; Saddi VA; Silva KSFE; Sugita DM; Guillo LA
Melanoma Res; 2021 Oct; 31(5):439-448. PubMed ID: 34433195
[TBL] [Abstract][Full Text] [Related]
11. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
12. Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
Belgorosky D; Girouard J; Langle YV; Hamelin-Morrissete J; Marino L; Agüero EI; Malagrino H; Reyes-Moreno C; Eiján AM
J Mol Med (Berl); 2020 Nov; 98(11):1615-1627. PubMed ID: 32955679
[TBL] [Abstract][Full Text] [Related]
13. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
14. Comparative analysis of Oct4 in different histological subtypes of esophageal squamous cell carcinomas in different clinical conditions.
Vaiphei K; Sinha SK; Kochhar R
Asian Pac J Cancer Prev; 2014; 15(8):3519-24. PubMed ID: 24870750
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of combination of CD90 and OCT4 for hepatocellular carcinoma after curative resection.
Zhao RC; Zhou J; Chen KF; Gong J; Liu J; He JY; Guan P; Li B; Qin Y
Neoplasma; 2016; 63(2):288-98. PubMed ID: 26674131
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of OCT4 expression in adenocarcinoma of the lung.
Zhang X; Han B; Huang J; Zheng B; Geng Q; Aziz F; Dong Q
Jpn J Clin Oncol; 2010 Oct; 40(10):961-6. PubMed ID: 20462980
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of breast cancer stem cell-like phenotype by Oct4 promoter-mediated activity.
Ghanei Z; Jamshidizad A; Joupari MD; Shamsara M
J Cell Physiol; 2020 Nov; 235(11):7840-7848. PubMed ID: 31904128
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract][Full Text] [Related]
19. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.
Rasti A; Mehrazma M; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Asgari M
Sci Rep; 2018 Aug; 8(1):11739. PubMed ID: 30082842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]